The saprophytic bacterium Serratia plymuthica was recovered from a facial wound (burn) site of a pediatric patient. The clinical significance of the organism was undetermined due to its apparent eradication from this location by therapy with topical 1% silver sulfadiazine. Seeding of the burn with S. plymuthica may have occurred from contaminated moisture sometimes found on and around steam radiators. 
The saprophytic bacterium Serratia plymuthica was recovered from a facial wound (burn) site of a pediatric patient. The clinical significance of the organism was undetermined due to its apparent eradication from this location by therapy with topical 1% silver sulfadiazine. Seeding of the burn with S. plymuthica may have occurred from contaminated moisture sometimes found on and around steam radiators. (5) confirmed the identity of the organism as S. plymuthica. The organism produced an alkaline-acid slant when inoculated onto Kilger's iron agar without the evolution of gas or the formation of hydrogen sulfide. In addition, positive reactions for S. plymuthica were recorded in the following tests: production of DNase and chitinase, use of citrate, growth at 4°C and in the presence of 0.2% acetate, nitrate reduction, acetylmeth-ylcarbinol formation, and motility. The organism fermented dextrose, maltose, sucrose, mannitol, raffinose, arabinose, xylose, lactose, salicin, sorbitol, and trehalose, but failed to use adonitol, dulcitol, or rhamnose (Table 1) .
This case report describes the first known isolation of S. plymuthica from a human wound site and indicates that this normally saprophytic organism may indeed be recovered from clinical material. Whenever possible, all arabinose-positive Serratia species (non-S. marcescens) isolated from human specimens should be identified to species level to more fully delineate the epidemiology of these newly designated saprophytic Serratia species (S. plymuthica, S. rubidaea, and S. ficaria). The API 20E identification system is fully capable of distinguishing S. plymuthica from the phenotypically related S. liquefaciens (4) without the necessity of supplementary biochemical tests. However, additional biochemical tests are required when identifying S. ficaria by other miniaturized systems (3, 8) .
The clinical significance of the S. plymuthica recovered from the burn site was undetermined due to the apparent eradication of the organism by topical treatment with 1% silver sulfadiazine (the organism was susceptible to sulfisoxazole). To date, S. plymuthica has not been associated with a human infection. The environmental source of the S. 
